Literature DB >> 1637884

Histologic findings in bone marrow biopsies of patients with thrombocythemic cell counts.

T Buhr1, A Georgii, O Schuppan, A Amor, V Kaloutsi.   

Abstract

Histologic diagnoses from bone marrow biopsies were analyzed in a total of 1165 patients presenting with thrombocythemic platelet counts at initial examination. Two cut-off points suggested by the Polycythemia Vera Study Group to define thrombocythemia by platelet counts were compared: the former limiting value of 1000 x 10(9)/l platelets versus the recently proposed value of 600 x 10(9)/l. The percentage of all nonproliferative disorders was 41% under the lower, dropping to 11% under the high cut-off point. The respective figures for myeloproliferative disorders increased from 49% under the lower to 74% under the high limiting value. Primary thrombocythemia was included in 72% by the lower, and in only 40% by the high limiting value when classified by its histologic pattern in bone marrow biopsy. A striking decrease of platelet counts occurs, related to fiber increase, among each of three main groups of myeloproliferative disorders: in CML with megakaryocytic predominance from 40% down to 25%, in megakaryocytic-granulocytic myelosis (primary, i.e., agnogenic myelofibrosis) from 36.6% to 10%, and in primary thrombocythemia from 72.6% to 28.6% in cases with reticulin sclerosis.

Entities:  

Mesh:

Year:  1992        PMID: 1637884     DOI: 10.1007/bf01695473

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  35 in total

1.  Primary hemorrhagic thrombocythemia.

Authors:  F L OZER; W E TRAUX; D C MIESCH; W C LEVIN
Journal:  Am J Med       Date:  1960-05       Impact factor: 4.965

2.  Essential thrombocythemia. Clinical characteristics and course of 61 cases.

Authors:  R Hehlmann; M Jahn; B Baumann; W Köpcke
Journal:  Cancer       Date:  1988-06-15       Impact factor: 6.860

3.  Primary thrombocythaemia: diagnostic criteria and a simple scoring system for positive diagnosis.

Authors:  J M Dudley; M Messinezy; S Eridani; L J Holland; A Lawrie; T O Nunan; B Sawyer; G F Savidge; T C Pearson
Journal:  Br J Haematol       Date:  1989-03       Impact factor: 6.998

4.  Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group.

Authors:  S Murphy; H Iland; D Rosenthal; J Laszlo
Journal:  Semin Hematol       Date:  1986-07       Impact factor: 3.851

5.  Primary or hemorrhagic thrombocythemia.

Authors:  M N Silverstein
Journal:  Arch Intern Med       Date:  1968-07

6.  Bone marrow biopsy with unaltered architecture: a new biopsy device.

Authors:  K Jamshidi; W R Swaim
Journal:  J Lab Clin Med       Date:  1971-02

7.  Primary (essential) thrombocythemia versus initial (hyperplastic) stages of agnogenic myeloid metaplasia with thrombocytosis--a critical evaluation of clinical and histomorphological data.

Authors:  J Thiele; R Zankovich; T Steinberg; B Kremer; R Fischer; V Diehl
Journal:  Acta Haematol       Date:  1989       Impact factor: 2.195

8.  Thrombotic and hemorrhagic complications in essential thrombocythemia. A retrospective study of 103 patients.

Authors:  M Colombi; F Radaelli; L Zocchi; A T Maiolo
Journal:  Cancer       Date:  1991-06-01       Impact factor: 6.860

Review 9.  Idiopathic myelofibrosis: historical review, diagnosis and management.

Authors:  I M Weinstein
Journal:  Blood Rev       Date:  1991-06       Impact factor: 8.250

10.  Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia.

Authors:  J Thiele; S Funke; S Holgado; H Choritz; A Georgii
Journal:  Anal Quant Cytol       Date:  1984-09
View more
  3 in total

1.  Molecular detection of c-mpl thrombopoietin receptor gene expression in chronic myeloproliferative disorders.

Authors:  S Duensing; A Duensing; J G Meran; A Kreft; G Büsche; A Ganser; A Georgii
Journal:  Mol Pathol       Date:  1999-06

Review 2.  Rethinking the diagnostic criteria of polycythemia vera.

Authors:  T Barbui; J Thiele; A M Vannucchi; A Tefferi
Journal:  Leukemia       Date:  2013-12-19       Impact factor: 11.528

Review 3.  Is it justified to perform a bone marrow biopsy examination in sustained erythrocytosis?

Authors:  Juergen Thiele; Hans Michael Kvasnicka
Journal:  Curr Hematol Malig Rep       Date:  2006-06       Impact factor: 3.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.